Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà

Âåðíóòüñÿ   Äèñêóññèîííûé Êëóá Ðóññêîãî Ìåäèöèíñêîãî Ñåðâåðà > Ôîðóìû âðà÷åáíûõ êîíñóëüòàöèé > Ýíäîêðèíîëîãèÿ > Ôîðóì äëÿ îáùåíèÿ âðà÷åé ýíäîêðèíîëîãîâ

Îòâåò
 
Îïöèè òåìû Ïîèñê â ýòîé òåìå Îïöèè ïðîñìîòðà
  #1  
Ñòàðûé 23.10.2015, 10:39
ELENA_VLAD ELENA_VLAD âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 24.07.2008
Ãîðîä: Êðàñíîÿðñê
Ñîîáùåíèé: 7,007
Ñêàçàë(à) ñïàñèáî: 278
Ïîáëàãîäàðèëè 2,155 ðàç(à) çà 2,080 ñîîáùåíèé
ELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Ëàçåðíàÿ äåñòðóêöèÿ

Âîò è â Êðàñíîÿðñêå ñòàëè âûïîëíÿòü â ïëàòíîì öåíòðå ëàçåðíóþ äåñòðóêöèþ óçëîâîãî çîáà.
Íå õî÷åòñÿ áðîñàòüñÿ â äðàêó, çàïðåùàòü, ïèñàòü êëÿóçû. Íî áîëüíûõ, êîòîðûì çàñëóæåííûé âðà÷ ÐÔ ëåò 70 âêóïå ñ ôèçèîòåðàïåâòîì ñóëÿò èçáàâëåíèå îò ñòðàøíûõ íåäóãîâ, æàëü. ×òî ïîñîâåòóåòå, êîëëåãè?
Îòâåòèòü ñ öèòèðîâàíèåì
  #2  
Ñòàðûé 24.10.2015, 11:01
Samitin Samitin âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 27.08.2009
Ãîðîä: Ñàðàòîâ
Ñîîáùåíèé: 2,224
Ñêàçàë(à) ñïàñèáî: 8
Ïîáëàãîäàðèëè 765 ðàç(à) çà 691 ñîîáùåíèé
Samitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Âñåì, êîãî æàëü, ïîìî÷ü, ê ñîæàëåíèþ, íåâîçìîæíî.
Ì.á., ìîãëè áû áûòü ïîëåçíû ðåêîìåíäàöèè äëÿ ïàöèåíòîâ, âûïóùåííûå ïîä ýãèäîé, íàïðìåð, ÝÍÖà è ÐÀÝ ïî îáðàçó è ïîäîáèþ òåõ èíôîðìàöèîííûõ áóêëåòîâ, êîòîðûå ñîçäàþò ìíîãèå çàðóáåæíûå àññîöèàöèè ñïåöèàëèñòîâ. Íî äëÿ ýòîãî êîìó-òî ïðèä¸òñÿ èõ ñîçäàòü.
Ïðîøó ïðîùåíèÿ çà ìàíèëîâùèíó.

Êîììåíòàðèè ê ñîîáùåíèþ:
ELENA_VLAD îäîáðèë(à): Ñïàñèáî!
Îòâåòèòü ñ öèòèðîâàíèåì
  #3  
Ñòàðûé 29.10.2015, 15:32
Iera Iera âíå ôîðóìà ÂÐÀ×
Ïîñòîÿííûé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 28.01.2010
Ãîðîä: Áàêó
Ñîîáùåíèé: 226
Ñêàçàë(à) ñïàñèáî: 45
Ïîáëàãîäàðèëè 9 ðàç(à) çà 4 ñîîáùåíèé
Iera ýòîò ó÷àñòíèê èìååò õîðîøóþ ðåïóòàöèþ íà ôîðóìå
À ïî÷åìó òàêîé ñêåïòèòèçì?
Âîò íîâàÿ ñòàòüÿ
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
Íå òàêèå óæ è ïëîõèå ðåçóëüòàòû, ÿ ñ÷èòàþ.

Ï.Ñ. Ðóññêîé êëàâèàòóðû íåò íà äàííèé ìîìåíò, èçâèíèòå.
Îòâåòèòü ñ öèòèðîâàíèåì
  #4  
Ñòàðûé 29.10.2015, 21:17
Samitin Samitin âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 27.08.2009
Ãîðîä: Ñàðàòîâ
Ñîîáùåíèé: 2,224
Ñêàçàë(à) ñïàñèáî: 8
Ïîáëàãîäàðèëè 765 ðàç(à) çà 691 ñîîáùåíèé
Samitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íå ñòîëüêî ñêåïñèñ, ñêîëüêî ïîçèòèâèçì: ÿ, íàïðèìåð, ÷åëîâåê ïðèìèòèâíûé, ïðèçåìëåííûé è æèâó ïî ãàéäàì, íàïèñàííûì äëÿ ìåíÿ óìíûìè ëþäüìè.  ãàéäàõ çíà÷èòñÿ, ÷òî äîáðîêà÷åñòâåííûé óçåë âíå ñäàâëåíèÿ/êîñìåòè÷åñêîãî äåôåêòà/àâòîíîìèè ìîæíî íå ëå÷èòü.
Èòàëüÿíöû ðàáîòàþò - ÷òî æ, ïóñòü èõ, êîëè ïàöèåíòû èíôîðìñîãëàñèå ïîäïèñûâàþò.
 ïîëíûé òåêñò âíèêàòü ñåé÷àñ íå ìîãó, íî ôðàçà èç àáñòðàêòà
Öèòàòà:
Mean nodule volume decreased from 27 ± 24 mL at baseline to 8 ± 8 mL 12 months after treatment (P < .001).
ñâèäåòåëüñòâóåò î òîì, ÷òî ñòàòèñòèêà â ðàáîòå âûïîëíåíà íå ëó÷øèì îáðàçîì, íî äàëåêî íå âñå óçëû èìåëè èñõîäíûé äèàìåòð áîëåå 3 ñì. Íî âñå çîáû áûëè ýóòèðåîèäíûìè. Òàê èç-çà ÷åãî ñûð-áîð? Õîòèì îñ÷àñòëèâèòü ïàöèåíòà óìåíüøåíèåì äèàìåòðà äîáðîêà÷åñòâåííîãî ýóòèðåîèäíîãî óçëà, êîòîðûé, ñ áîëüøîé âåðîÿòíîñòüþ, èñõîäíî íèêàêèõ ïðîáëåì íå ñîçäàâàë?

Âïðî÷åì, âñ¸ äåëî â ìîòèâàöèè è öåíå íà áèëåòû...

Êîììåíòàðèè ê ñîîáùåíèþ:
o_udovichenko îäîáðèë(à):
Îòâåòèòü ñ öèòèðîâàíèåì
  #5  
Ñòàðûé 29.10.2015, 21:24
Àâàòàð äëÿ Melnichenko
Melnichenko Melnichenko âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 26.07.2001
Ãîðîä: Ìîñêâà
Ñîîáùåíèé: 117,546
Ñêàçàë(à) ñïàñèáî: 26
Ïîáëàãîäàðèëè 33,719 ðàç(à) çà 32,792 ñîîáùåíèé
Melnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåMelnichenko ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
À ïðèïàÿòü ê îêðóæàþùèì òêàíÿì óæàñòü êàê íàäî ..è íàáëþäàòü çà äèâíîé êðàñîòîé ïðîëå÷åííîãî íèâåñòü ïî÷åìó ó÷àñòêà òîæå ïðèÿòíî. Íî îïÿòü íå íåëüçÿ çàïðåòèòü ëå÷èòü çäîðîâûõ
__________________
Ã.À. Ìåëüíè÷åíêî
Îòâåòèòü ñ öèòèðîâàíèåì
  #6  
Ñòàðûé 29.10.2015, 21:54
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad íà ôîðóìå
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,844
Ïîáëàãîäàðèëè 33,440 ðàç(à) çà 31,783 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Äîáàâëþ, ÷òî â èòàëüÿíñêîì èññëåäîâàíèè ñèìïòîìû (ñäàâëåíèÿ?) èñõîäíî áûëè ó ~50% è êîñìåòè÷åñêèå ïðîáëåìû/äåôåêòû ó 86% ïàöèåíòîâ, òàê ÷òî ó áîëüøèíñòâà áûëè ïîêàçàíèÿ, î êîòîðûõ óïîìèíàåòñÿ âûøå; êðîìå ëàçàðÿ, â ðàçíûõ ìåñòàõ ïðîáóþò ïðàêòèêîâàòü äðóãèå ìåòîäèêè òåðìàëüíîé àáëàöèè Radiofrequency ablation (RFA), Microwave ablation (MWA), High-intensity focused US (HIFU) ablation,÷òî îáîçðåâàþò çäåñü:
Nonsurgical, Image-Guided, Minimally Invasive Therapy for Thyroid Nodules
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

äðóãîå äåëî, êîãäà òîé èëè èíîé ïðîöåäóðîé çëîóïîòðåáëÿþò áåç ïîêàçàíèé, è ðèñê òîãî, ÷òî ëþáûå âûÿâëåííûå íà ÓÇÈ óçëû ñðàçó áóäóò íàïðàâëÿòüñÿ íà àáëàöèþ íå äîæèäàÿñü ðîñòà/êîñìåòèêè/ñèìïòîìîâ âåñüìà âûñîê â óñëîâèÿõ íàøåãî çäðàâîîõðàíåíèÿ.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #7  
Ñòàðûé 29.10.2015, 22:24
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad íà ôîðóìå
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,844
Ïîáëàãîäàðèëè 33,440 ðàç(à) çà 31,783 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Äîáàâëþ, ÷òî îäèí (ñòàðøîé) èç àâòîðîâ òîé ðàáîòû èç Èòàëèè, ãîäîì ðàíåå îïóáëèêîâàë åùå îäíó ñòàòüþ:

Long-term Efficacy of Ultrasound-Guided Laser Ablation for Benign Solid Thyroid Nodules.
Results of a Three-Year Multicenter Prospective Randomized Trial
[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]

êîòîðàÿ åñòü â ñâîá. äîñòóïå è ãäå âèäíû âñå êðèòåðèè âêëþ÷åíèÿ:

200 of over 2000 consecutive patients with a single or dominant thyroid nodule were enrolled by four Italian thyroid referral centers over a 1-year period. All patients were referred because of a palpable nodule that caused cosmetic or pressure symptoms.
Entry criteria were: solid thyroid nodule with a volume of 6–17 mL, with at least one diameter greater than 30 mm; repeat (at least two) benign cytological findings; normal serum TSH, free T4 (FT4), and free T3 values; hypoactive or nondelineated appearance at 99mTc thyroid scintiscan; no thyroid autoimmunity process; and no prior thyroid gland treatment.

Ñëîæíî ïîäîçðåâàòü èìåííî ýòèõ àâòîðîâ èç Èòàëèè â íåñîáëþäåíèè êðèòåðèåâ äëÿ îòáîðà íà ëàçåðíóþ àáëàöèþ, êîãäà òå æå àâòîðû ïèñàëè ðåêîìåíäàöèè è äëÿ âñåãî öèâèëèçîâàííîãî ìèðà ýíäîêðèíîëîãîâ:

J Endocrinol Invest. 2010;33(5 Suppl):51-6.
American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations.
Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, Vitti P; AACE/AME/ETA Task Force on Thyroid Nodules.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #8  
Ñòàðûé 29.10.2015, 23:29
Samitin Samitin âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 27.08.2009
Ãîðîä: Ñàðàòîâ
Ñîîáùåíèé: 2,224
Ñêàçàë(à) ñïàñèáî: 8
Ïîáëàãîäàðèëè 765 ðàç(à) çà 691 ñîîáùåíèé
Samitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Âàäèì Âàëåðüåâè÷ òàêè çàñòàâèë ìåíÿ ê ïîëóíî÷è â÷èòûâàòüñÿ â ñòàòüþ èç ïîñòà #3.

Íèêîãî íå ïîäîçðåâàþ â íåñîáëþäåíèè êðèòåðèåâ îòáîðà íà ëàçåðíóþ àáëàöèþ, ò.ê. â öèâèëèçîâàííûé ãàéä ýòîò ìåòîä íå ïðîøåë, è êàêèå ìîãóò áûòü ê íåìó ïîêàçàíèÿ - íå çíàþ. Íàïèñàë âåäü, ÷òî àâòîðû ìîãóò ðàçâëåêàòüñÿ êàê õîòÿò, ïîêà GCP ñîáëþäàþò, à ïàöèåíòû ñîãëàñíû.

Ïðåäñòàâëåíèå äàííûõ, êàê ìíå êàæåòñÿ, íèêóäà íå ãîäèòñÿ.
Öèòàòà:
The mean volume of the treated nodules was 27+/-24 mL (range,1.4–216mL).
Êîñìåòè÷åñêèé äåôåêò, îáóñëîâëåííûé óçëîì îáúåìîì 1,5 ìë? Ñäàâëåíèå? Íè÷åãî íå ïîäîçðåâàþ, ïðîñòî èíòåðåñóþñü, êàê ýòî âûãëÿäèò. È êàê â îáû÷íîé æèçíè ìîæåò áåñïîêîèòü (è ìîæåò áûòü âûÿâëåí) êîñìåòè÷åñêèé äåôåêò, âûÿâëÿåìûé ëèøü ïðè ïåðåðàçãèáàíèè øåè. Ìåäèàíû èëè ãðàäàöèÿ îáúåìîâ ïî ÷àñòîòå íå óêàçàíû. Èñêëþ÷àëñÿ ëè íåâðîòè÷åñêèé êîìîê - íå çíàþ.
Îñîáûé îïòèìèçì âñåëÿåò òî, ÷òî ñòåïåíü ðåäóêöèè îáúåìà îêàçàëàñü ïðèìåðíî îäèíàêîâîé äëÿ óçëîâ, êîòîðûå àâòîðû îáîçíà÷èëè êàê ìàëûå, ñðåäíèå è áîëüøèå. ×èòàë, êàþñü, ïî äèàãîíàëè, íî ïðèâÿçêè ýòèõ îïðåäåëåíèé ê êîíêðåòíûì îáúåìàì íå íàøåë.

Ñòàòüÿ ìíå íå íðàâèòñÿ. Íî, êàê áûëî ñêàçàíî âûøå, ìîòèâàöèÿ è öåíû íà áèëåòû ðåøàþò.
Âîò íèêîìó óäàëåíèå ÙÆ èç ïîäìûøå÷íîé îáëàñòè íå ðåêîìåíäîâàë, íî â ñðàâíåíèè ñ ëàçåðíûì âîçäåéñòâèåì äàæå ýòî âûãëÿäèò êàê-òî íàäåæíåå. Óæ åñëè áåðåìñÿ çà óçåë, òî õîòü ãèñòîëîãèþ ïîòîì ïîëó÷èì...
Îòâåòèòü ñ öèòèðîâàíèåì
  #9  
Ñòàðûé 30.10.2015, 00:06
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad íà ôîðóìå
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,844
Ïîáëàãîäàðèëè 33,440 ðàç(à) çà 31,783 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìûé Âàñèëèé,

Åñëè ïîñìîòðåòü ïî äàòàì, òî ïåðâûå ïàöèåíòû íàáëþäàëèñü ñ 2004, êîãäà íèêàêèõ ãàéäîâ/êîíñåíñóñîâ ïî óçëàì íå áûëî è êàæäûé áûë êòî âî ÷òî ãîðàçä, â ýòîì æå ãîäó áûëà îò Ïàïèíè Å. ïåðâàÿ ïóáëèêàöèÿ, ãäå êðèòåðèè áûëè, âêëþ÷àÿ:

The criteria for entry into the study were as follows: (1) presence of a hypofunctioning thyroid nodule with a volume exceeding 8 mL, (2) benign cytologic findings, (3) local compression symptoms or patient concern, and (4) refusal of or ineligibility for surgical treatment.

Endocr Pract. 2004 May-Jun;10(3):276-83.
Ultrasound-guided laser thermal ablation for treatment of benign thyroid nodules.
Papini E,

Íå óäèâëþñü, ÷òî ñðåäè 8 öåíòðîâ Èòàëèè çà 9 ëåò êòî-òî êîãäà-òî ïî êàêèì-òî ïðè÷èíàì âêëþ÷èë ïàöèåíòîâ ñ ðàçìåðîì óçëîâ ìåíåå 3 ñì èëè 1.5 ìë îáüåìà.

Êñòàòè, â ðåêîìåíäàöèÿõ çà 2010

American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations

ïðî ëàçàðü åñòü îòäåëüíûé ñòåéòìåíò:

7.6.2.5. Image-Guided Thermal Ablation
• Laser ablation may be considered for the treatment
of thyroid nodules causing pressure symptoms
or cosmetic issues in patients who decline
surgery or are at surgical risk. Its use should be restricted
to specialized centers (Grade C; BEL 2)

[Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #10  
Ñòàðûé 30.10.2015, 00:21
Samitin Samitin âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 27.08.2009
Ãîðîä: Ñàðàòîâ
Ñîîáùåíèé: 2,224
Ñêàçàë(à) ñïàñèáî: 8
Ïîáëàãîäàðèëè 765 ðàç(à) çà 691 ñîîáùåíèé
Samitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Óâàæàåìûé Âàäèì Âàëåðüåâè÷, èìåííî â ñâÿçè ñ òåì, ÷òî êàæäûé áûë êòî âî ÷òî ãîðàçä, ÿ íèêîãî íå ïîäîçðåâàþ â íåñîáëþäåíèè êðèòåðèåâ îòáîðà íà ëàçåðíóþ àáëàöèþ. Ñòåéòìåíò åñòü, íî, ñîãëàñèòåñü, âñå, ÷òî ñîäåðæèò "may be (a may è íå be) considered", èìååò óðîâåíü Ñ2 è ïðåäëàãàåòñÿ ê èñïîëüçîâàíèþ â óçêîñïåöèàëèçèðîâàííûõ öåíòðàõ, ãäå ýòèì çàíèìàþòñÿ, âðÿä ëè ïðèìåíèìî ê ìîåé ïðèìèòèâíîé è ïðèçåìëåííîé ïîâñåäíåâíîé ïðàêòèêå.
Âîò êîãäà óçêîñïåöèàëèçèðîâàííûå öåíòðû ïåðåñòàíóò â 2015 ãîäó ïóáëèêîâàòü ñòàòüè ñ äàííûìè ïðî 1.5 ìë ðîäîì èç 2004 ãîäà, íàêîïÿò áîëåå ðåëåâàíòíûé îïûò è ñìîãóò îòñòîÿòü áîëåå ïðèëè÷íûé óðîâåíü ðåêîìåíäàòåëüíîñòè â îáíîâëåíîì ãàéäå - òóò óæ è ÿ ïîçèòèâèñòñêè ïðèñîåäèíþñü...

×òî æå êàñàåòñÿ "patient concern" - ïîâòîðþñü: áûëî áû íåïëîõî âèäåòü, ÷òî àâòîðû èñêëþ÷èëè òðåâîæíûé ñèíäðîì äî òîãî, êàê áðàòüñÿ çà ëàçåð.
Îòâåòèòü ñ öèòèðîâàíèåì
  #11  
Ñòàðûé 30.10.2015, 00:28
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad íà ôîðóìå
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,844
Ïîáëàãîäàðèëè 33,440 ðàç(à) çà 31,783 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ïî ãðàäàöèè óçëîâ: nodules with initial volume of 13 mL or less were classified as small, those between 13.1 and 30.0 mL as medium, and those greater than 30 mL as large.

ïî ýôôåêòèâíîñòè â çàâèñèìîñòè îò ðàçìåðîâ:
In more detail, the local symptoms score improved from 15% to 3% in small nodules (P.001), from 42% to 11% in medium nodules (P  .001), and from 90% to 19% in large nodules (P  .001). Evidence of cosmetic score improved from 80% to 5% in small nodules (P  .001), from 86% to 8% in medium nodules (P  .001), and from 93% to 14% in large nodules (P  .001).

Êàê âèäíî êîñìåòè÷åñêèå ïðåòåíçèè ïðåîáëàäàëè ñðåäè ïàöèåíòîâ ñ ìåëêèìè óçëàìè, à êëèíè÷åñêèå ñèìïòîìû áûëè â îñíîâíîì ïðè êðóïíûõ óçëàõ, òåîðåòè÷åñêè-àðèôìåòè÷åñêè êàê ìèíèìóì 5% ïàöèåíòîâ ñ ìàëûìè óçëàìè íå ïðåäüÿâëÿëè íè êîñìåòè÷åñêèõ ïðåòåíçèé, íè æàëîá (íàâåðíîå òå ñàìûå ñ îáüåìîì îò 1.4 ìë è äî 3 ñì â äèàìåòðå); èíòåðåñíî, ÷òî â êëèíèêå Alzano Lombardo ñðåäè ïðåèìóùåñòâåííî ïàöèåíòîê (32 èç 36) ñî ñð. îáüåìîì 5 ìë (2-21 ìë) ÷åðåç ãîä ïîñëå ïðîöåäóðû îáüåì ñòàë 8.4 ìë, ÷òî íàìåêàåò, ÷òî ëàçåðîàáëàöèÿ ìåëêèõ óçëîâ íå óìåíüøàåò èõ âåëè÷èíó.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #12  
Ñòàðûé 30.10.2015, 00:33
Samitin Samitin âíå ôîðóìà ÂÐÀ×
Âðà÷-ó÷àñòíèê ôîðóìà
      
 
Ðåãèñòðàöèÿ: 27.08.2009
Ãîðîä: Ñàðàòîâ
Ñîîáùåíèé: 2,224
Ñêàçàë(à) ñïàñèáî: 8
Ïîáëàãîäàðèëè 765 ðàç(à) çà 691 ñîîáùåíèé
Samitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåSamitin ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
ß ãîâîðþ î íåäîñòàòêàõ ëèøü ïóáëèêàöèè èç ïîñòà #3, â íåé ðàçìåðû óçëîâ íå êëàññèôèöèðîâàíû (ñ ïëàíøåòèêà ìíå çà Âàìè íå óãíàòüñÿ, íî ïîèñê â .pdf'å ïî ñëîâó "as small" ðåçóëüòàòîâ íå äàë). Äîëæíî áûòü, Âû ïðèâîäèòå äàííûå èç äðóãîé ñòàòüè.

À íåò, âèíîâàò - åñòü ýòè äàííûå. Ó ìåíÿ ïî÷åìó-òî ïîèñê ïî ñëîâîñî÷åòàíèþ ñáîèò...
Îòâåòèòü ñ öèòèðîâàíèåì
  #13  
Ñòàðûé 30.10.2015, 00:39
Àâàòàð äëÿ Dr.Vad
Dr.Vad Dr.Vad íà ôîðóìå
Ìîäåðàòîð ôîðóìà ïî ãåìàòîëîãèè
      
 
Ðåãèñòðàöèÿ: 16.01.2003
Ãîðîä: Õüþñòîí, Òåõàñ
Ñîîáùåíèé: 80,844
Ïîáëàãîäàðèëè 33,440 ðàç(à) çà 31,783 ñîîáùåíèé
Dr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåDr.Vad ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Àáñîëþòíî ñîãëàñåí ïî ïîâîäó ïîâñåäíåâíîé ïðàêòèêè, òîëüêî äëÿ öåíòðîâ, òà æå Radiofrequency ablation, êîòîðóþ áîëåå ÷àñòî â ñðàâíåííèè ñ ëàçåðîì èñïîëüçóþò â òåõ æå ñïåöèàëèç. öåíòðàõ ìèðà ñ òîé æå öåëüþ íå ïîëó÷èëà îäîáðåíèÿ â òåõ æå ðåêîìåíäàöèÿõ çà 2010:
RFA is not recommended in the routine management of thyroid nodules (Grade C; BEL 3)

õîòÿ îòå÷åñòâåííûé îïûò (íàäåþñü, ÷òî â ñïåöèàëèç. öåíòðå è ñ ñîãëàñèÿ ïàöèåíòà) èìååòñÿ:

Khirurgiia (Mosk). 2014;(9):81-5.
[Radiofrequency ablation in treatment of thyroid gland nodules].
[Article in Russian]
Verevkina NA, Solov'ev NA, Panchenkov DN, Ivanov IuV, Silaev MA.
__________________
Èñêðåííå,
Âàäèì Âàëåðüåâè÷.
Îòâåòèòü ñ öèòèðîâàíèåì
  #14  
Ñòàðûé 30.10.2015, 08:02
ELENA_VLAD ELENA_VLAD âíå ôîðóìà
ÂÐÀ×
      
 
Ðåãèñòðàöèÿ: 24.07.2008
Ãîðîä: Êðàñíîÿðñê
Ñîîáùåíèé: 7,007
Ñêàçàë(à) ñïàñèáî: 278
Ïîáëàãîäàðèëè 2,155 ðàç(à) çà 2,080 ñîîáùåíèé
ELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìåELENA_VLAD ýòîò ó÷àñòíèê èìååò ïðåâîñõîäíóþ ðåïóòàöèþ íà ôîðóìå
Íà ìåñòíîì óðîâíå ðåøèëà ïðîñòî ïîíàáëþäàòü è äîæäàòüñÿ, êîãäà ïîëó÷èâøèå ýòî ëå÷åíèå íà÷íóò ïðèõîäèòü êî ìíå. Ïðè÷åì èíèöèèðóåò ýòó òåðàïèþ äàìà çà 70 ëåò, èç òåõ, êòî ëå÷èò òèðîêñèíîì óçëû " ñ ïðåêðàñíûìè ðåçóëüòàòàìè". Ïî òðåòüåìó êðóãó, âèäèìî ïîøëî... Ñåðòèôèêàòà ýíäîêðèíîëîãà ó íåå íåò äàâíî, íî ðàáîòàåò.
Îòâåòèòü ñ öèòèðîâàíèåì
  #15  
Ñòàðûé 10.11.2015, 18:47
margarita62 margarita62 âíå ôîðóìà ÂÐÀ×
Íà÷èíàþùèé ó÷àñòíèê
 
Ðåãèñòðàöèÿ: 01.11.2012
Ãîðîä: ìîñêîâñêàÿ îáëàñòü
Ñîîáùåíèé: 56
Ñêàçàë(à) ñïàñèáî: 34
margarita62 ýòîò ó÷àñòíèê èìååò õîðîøóþ ðåïóòàöèþ íà ôîðóìå
À êàê íà ñ÷åò àáëÿöèè óçëîâ ñ õîðîøåé ÔÀ? Ó êîãî-òî åñòü îïûò?
Îòâåòèòü ñ öèòèðîâàíèåì
Îòâåò



Âàøè ïðàâà â ðàçäåëå
Âû íå ìîæåòå ñîçäàâàòü òåìû
Âû íå ìîæåòå îòâå÷àòü íà ñîîáùåíèÿ
Âû íå ìîæåòå ïðèêðåïëÿòü ôàéëû
Âû íå ìîæåòå ðåäàêòèðîâàòü ñîîáùåíèÿ

BB êîäû Âêë.
Ñìàéëû Âêë.
[IMG] êîä Âêë.
HTML êîä Âûêë.



×àñîâîé ïîÿñ GMT +3, âðåìÿ: 20:43.




Ðàáîòàåò íà vBulletin® âåðñèÿ 3.
Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.